Ebola Vaccine Trial (Ad26.ZEBOV/MVA-BN-Filo)
Condition: Ebola Virus Disease Intervention: Drug: Ad26.ZEBOV/MVA-BN-Filo Sponsors: MRC/UVRI Uganda Research Unit on Aids; Epicentre, Paris, France and Mbarara, Uganda; Janssen Pharmaceutica N.V., Belgium; Coalition for Epidemic Preparedness Innovations Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AIDS Vaccine | Belgium Health | Ebola | Ebola Vaccine | Epidemics | Epidemiology | HIV AIDS | Research | Uganda Health | Vaccines